Review provides solid, reaffirming scientific data in support of using the medication for acne.
Treating acne in pregnancy requires familiarity with FDA medication categories and having thorough discussions with patients.
Dermatologists should discuss cost and insurance coverage concerns with patients to boost adherence to acne medication, researchers report in JAMA Dermatology.
Poor quality trials make assessing effects of non-pharmacological treatments in acne difficult, but based on the evidence, glycolic acid, amino fruit acid, intense pulsed light and diode laser are the most promising.
Between 2004 and 2013, the number of spironolactone courses per 100 females with acne rose from 2.08 to 8.13 among dermatologists and from 1.43 to 4.09 among nondermatologists, researchers report.
The transgender dermatology patient may face a unique set of challenges doctors should be prepared to address, says Dr. Brian Ginsberg.
Female patients with hormonal acne that typically flares before or after menstrual cycles may be ideal candidates for spironolactone, said Emmy M. Graber, M.D., president of the Dermatology Institute of Boston who spoke at AAD 2018 in San Diego this week.
Despite recommendations to limit the use of oral antibiotics, dermatologists continue to prescribe them in high numbers, according to results of a large, retrospective analysis of U.S. prescribing trends from 2004 to 2013.
Dermatologist evaluations of patient acne photos submitted via smartphone compare favorably to in-person evaluations, a JAMA Dermatology study shows.
The cost of doxycycline hyclate prescriptions increased 1,854% between 2011 and 2013 in a retrospective analysis of commercial claims data, and there was no association between market concentration and price of the oral antibiotic. Clinician or pharmacy level interventions to choose less costly oral tetracycline-class antibiotics could result in substantial cost savings.